InMode to Present at Upcoming Investor Conferences

Rhea-AI Summary

InMode (Nasdaq: INMD), a leading global provider of innovative medical technologies, has announced its participation in two major investor conferences in March 2025:

• Barclays 27th Annual Global Healthcare Conference on March 12 at 9:00 am EDT in Miami, FL, featuring CFO Yair Malca in a fireside chat moderated by Senior Equity Analyst Matt Miksic
• Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 18 at 9:20 am EDT, featuring CEO Moshe Mizrahy and CFO Yair Malca in a virtual fireside chat moderated by Senior Equity Analyst Suraj Kalia

Both events will include one-on-one meetings and offer live webcasts of the presentations.

News Market Reaction

+0.91%

1 alert

+0.91% News Effect

On the day this news was published, INMD gained 0.91%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

YOKNEAM, Israel, March 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in March:

Barclays 27^th Annual Global Healthcare Conference

Presenters: Yair Malca, Chief Financial Officer 

Format: In-person fireside chat moderated by Matt Miksic, Senior Equity Analyst, and one-on-one meetings

Location: Miami, FL

When: Wednesday, March 12 at 9:00 am EDT

A live webcast of the presentation can be accessed here.

Oppenheimer 34^th Annual Healthcare MedTech & Services Conference

Presenters: Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer

Format: Virtual fireside chat moderated by Suraj Kalia, Senior Equity Analyst, and one-on-one meetings

When: Tuesday, March 18 at 9:20 am EDT

A live webcast of the presentation can be accessed here.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com 

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-upcoming-investor-conferences-302387848.html

SOURCE InMode Ltd.

FAQ

When is InMode (INMD) presenting at the Barclays Healthcare Conference in March 2025?

InMode will present at the Barclays Conference on Wednesday, March 12, 2025, at 9:00 am EDT in Miami, FL.

What is the format of InMode's presentation at the Oppenheimer Healthcare Conference 2025?

InMode will participate in a virtual fireside chat with one-on-one meetings, featuring CEO Moshe Mizrahy and CFO Yair Malca on March 18 at 9:20 am EDT.

Which InMode executives are presenting at the March 2025 investor conferences?

CFO Yair Malca will present at Barclays, while both CEO Moshe Mizrahy and CFO Yair Malca will present at Oppenheimer.

Are the InMode (INMD) March 2025 investor conference presentations available for public viewing?

Yes, live webcasts of both the Barclays and Oppenheimer conference presentations will be accessible to the public.